CrystalGenomics Inc (083790) — Cash Flow Reinvestment Rate

Latest as of June 2018: 1.13x

CrystalGenomics Inc (083790) has a Cash Flow Reinvestment Rate of 1.13x as of June 2018, reinvesting ₩4.76 Billion (capex ₩22.51 Million plus investments ₩-4.73 Billion) from operating cash flow of ₩4.21 Billion. Explore reinvestment intensity of CrystalGenomics Inc to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.13x

(Capex + Investments) / Operating CF

Total Reinvested

₩4.76 Billion

Capex + Investments

Operating Cash Flow

₩4.21 Billion

KRW

Capital Expenditures

₩22.51 Million

KRW

CrystalGenomics Inc Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for CrystalGenomics Inc across 1 annual periods. Also explore how large is CrystalGenomics Inc's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for CrystalGenomics Inc (2017–2017)

Year-by-year capital reinvestment analysis for CrystalGenomics Inc. For live market cap and broader valuation context, see 083790 stock market capitalisation.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2017	10.14x	₩16.55 Billion	₩1.63 Billion	₩10.74 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow